Durable efficacy and manageable safety in patients age≥75 years with relapsed/refractory large B-cell lymphoma treated with tisagenlecleucel in the real-world setting Meeting Abstract
| Authors: | Landsburg, D. J.; Heim, M.; Moskop, A.; Foley, S. R.; Hill, B. T.; Schofield, G.; Jacobson, C.; Jaglowski, S. M.; Locke, F. L.; Ram, R.; Riedell, P. A.; Shah, G. L.; Popplewell, L. L.; Tiwari, R.; Lim, S.; Maier, H. J.; Majdan, M.; Pasquini, M.; Frigault, M. J. |
| Abstract Title: | Durable efficacy and manageable safety in patients age≥75 years with relapsed/refractory large B-cell lymphoma treated with tisagenlecleucel in the real-world setting |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3496 |
| Language: | English |
| ACCESSION: | WOS:001159740304107 |
| DOI: | 10.1182/blood-2023-179387 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
